ALDEYRA

At Aldeyra, we are devoted to developing medications to enhance the well-being of patients dealing with immune-mediated and metabolic illnesses. Our portfolio of product candidates are designed to target the inhibition of inflammatory cells associated with both ocular and systemic ailments, filling the gaps left by existing treatments. Through multiple ongoing clinical trials, our singular objective is to empower patients in achieving healthier and more fulfilling lives... LEXINGTON, Mass. --(BUSINESS WIRE)--Oct. 3, 2024-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the resubmission of a New Drug ...

Also known as: Aldeyra Pharmaceuticals, Inc., Aldeyra Therapeutics, Aldeyra Therapeutics, Inc.

Primary location: Lexington United States